MetLife Investment Management’s ChampionX CHX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-214,206
Closed -$5.32M 2857
2025
Q2
$5.32M Buy
214,206
+751
+0.4% +$18.9K 0.03% 554
2025
Q1
$6.36M Sell
213,455
-6,366
-3% -$186K 0.03% 502
2024
Q4
$5.98M Buy
219,821
+16,643
+8% +$495K 0.03% 460
2024
Q3
$6.13M Sell
203,178
-4,119
-2% -$130K 0.04% 428
2024
Q2
$6.88M Buy
207,297
+5,239
+3% +$179K 0.04% 345
2024
Q1
$7.25M Sell
202,058
-6,332
-3% -$189K 0.05% 326
2023
Q4
$6.09M Sell
208,390
-4,978
-2% -$154K 0.04% 361
2023
Q3
$7.6M Sell
213,368
-7,012
-3% -$249K 0.06% 265
2023
Q2
$6.84M Sell
220,380
-2,194
-1% -$60.4K 0.05% 314
2023
Q1
$6.04M Sell
222,574
-3,709
-2% -$111K 0.04% 354
2022
Q4
$6.56M Sell
226,283
-8,182
-3% -$226K 0.05% 316
2022
Q3
$4.59M Sell
234,465
-1,837
-0.8% -$37.9K 0.04% 449
2022
Q2
$4.69M Buy
236,302
+1,346
+0.6% +$30.4K 0.04% 458
2022
Q1
$5.75M Buy
234,956
+66,921
+40% +$1.55M 0.04% 433
2021
Q4
$3.4M Buy
168,035
+978
+0.6% +$23K 0.03% 616
2021
Q3
$3.74M Sell
167,057
-145
-0.1% -$3.31K 0.03% 517
2021
Q2
$4.29M Sell
167,202
-2,737
-2% -$66.6K 0.04% 467
2021
Q1
$3.69M Sell
169,939
-14,822
-8% -$288K 0.03% 553
2020
Q4
$2.83M Sell
184,761
-4,693
-2% -$52.1K 0.03% 654
2020
Q3
$1.51M Sell
189,454
-3,924
-2% -$37.8K 0.02% 844
2020
Q2
$1.89M Buy
193,378
+148,915
+335% +$1.36M 0.02% 735
2020
Q1
$256K Hold
44,463
﹤0.01% 1566
2019
Q4
$1.5M Sell
44,463
-589
-1% -$16K 0.02% 919
2019
Q3
$1.22M Sell
45,052
-799
-2% -$23.3K 0.01% 974
2019
Q2
$1.54M Sell
45,851
-1,302
-3% -$47.3K 0.02% 926
2019
Q1
$1.94M Sell
47,153
-7
-0% -$259 0.02% 838
2018
Q4
$1.28M Sell
47,160
-190
-0.4% -$6.99K 0.02% 937
2018
Q3
$2.06M Buy
+47,350
New +$1.98M 0.02% 842

Other funds holding CHX

MetLife Investment Management's CHX Position: Q3 2025 in Review

MetLife Investment Management sold out of ChampionX (CHX) in Q3 2025, closing a stake of 214,206 shares — an estimated $5.32M sold.

MetLife Investment Management first reported a position in CHX in Q3 2018 and held it in 28 quarters. The position peaked at $7.6M in Q3 2023. 3 funds tracked by Wall St. Rank hold CHX as of Q3 2025.

  • MetLife Investment Management reported no remaining ChampionX position as of Q3 2025 after selling out during the quarter.
  • MetLife Investment Management sold 214,206 ChampionX shares in Q3 2025, an estimated $5.32M.
  • MetLife Investment Management first reported a position in ChampionX in Q3 2018 and held it in 28 quarters.
  • MetLife Investment Management's ChampionX position peaked at $7.6M in Q3 2023.
  • 3 funds tracked by Wall St. Rank held ChampionX as of Q3 2025.

Based on MetLife Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.